FSSNX | VVERX | FSSNX / VVERX | |
Total Expense Ratio | 0.03 | 0.77 | 3% |
Annual Report Gross Expense Ratio | 0.03 | 1.01 | 2% |
Fund Existence | 14 years | 6 years | - |
Gain YTD | 0.650 | -4.060 | -16% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.9B | 92.6M | 27,970% |
Annual Yield % from dividends | 0.90 | 1.60 | 56% |
Returns for 1 year | 9.47 | -9.73 | -97% |
Returns for 3 years | 21.54 | -16.46 | -131% |
Returns for 5 years | 48.25 | -4.85 | -996% |
Returns for 10 years | 81.84 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WTID | 14.88 | 0.35 | +2.39% |
MicroSectors™ Energy -3X Invrs Lvrgd ETN | |||
SCHF | 22.20 | 0.18 | +0.82% |
Schwab International Equity ETF™ | |||
FFC | 16.31 | 0.03 | +0.18% |
Flaherty & Crumrine Preferred and Income Securities Fund | |||
FPAG | 34.06 | -0.02 | -0.07% |
FPA Global Equity ETF | |||
BIB | 50.23 | -1.29 | -2.50% |
ProShares Ultra Nasdaq Biotechnology |